analysis using a murine cDNA probe (Hindlll fragment, 900 bp) showed that CD34 was highly expressed in the brain and testis, and moderately in the thymus, spleen, and bone marrow, but not in adult liver. However, day 12 to 14 fetal liver cells showed significant expression of CD34. Quantitative reverse transcription polymerase chain reaction showed that spleen, thymus, bone marrow, and testis RNA gave two bands of almost equal intensity, but in the brain a novel clone was expressed three times more than the other clone. Furthermore, Northern blot analysis using a probe (156 bp) specific for the spliced intracellular region confirmed the significant mRNA expression of a novel clone. Although the biologic significance of alternative splicing remains to be elucidated, it is suggested that a different carboxyterminal tail causes a change in signal transduction. species. Recently, Brown et all3 isolated a murine CD34 cDNA clone from a bone marrow cDNA library.
We have cloned two different types of CD34 cDNA from a murine stromal cell line. In this report, we show that they are generated by alternative splicing and discuss this biofogic function.
MATERIALS AND METHODS
Cell lines and murine tissues. Liver, thymocyte, spleen, bone marrow, brain, and testis were isolated from BALB/c mice. Female BALB/c mice were mated with males on day 0, then pregnant mice were killed on days 12 to 20 by cervical dislocation. Livers with pigmentation were removed and single cell suspensions were prepared.
The murine stromal cell line, PA-6 was established by Dr Hiroaki Kodama (Ohu University, Kohriyama, Japan).I4 Cells were cultured in a-medium (Flow Laboratories, North Ryde, Australia) containing 10% fetal calf serum (FCS; Flow) in a 100 mm dish (Corning Glass Works, Corning NY). When confluent, the cells were incubated in medium with 1 pg/mL lipopolysaccharide (LPS), Escherichia coli Olll:B4 (Difco Laboratories, Detroit, MI) and 1 ng/mL 12-o-tetradecanoylphorbol 13-acetate (TPA) (Sigma Chemical Co) or 10 U/mL IL-la, or cocultured with DW34/7 for 3 days. 15 Mouse myeloid leukemia cells (Ml) were also cultured in a-medium containing 10% FCS. To induce differentiation, 20 ng/mL human recombinant (r) interleukin-6 (IL-6; Ajinomoto Co, Kawasaki, Japan), 100 U/mL human r leukemia inhibitory factor (LIF Asahi Chemical Industry Co, Fuji, Japan) or 20 ng/mL human r granulocyte colony-stimulating factor (G-CSF; Chugai Pharmaceutical Co, Tokyo, Japan) were added and cultured for 3 days.
The expression of CD34 mRNA was screened in the other murine cell lines, P815 (mastocytoma),16 IC-2 (mast ceIl),l7 ST-2 (stromal cell),'* WEHI3 (myelomonocytic leukemia),I9 FWCP2 (myeloid progenitor NFS60 (myeloid progenitor DA-1 (myeloid progenitor cell)," GRSL (spontaneous leukemia DW34/7 (B ce11),18 and 7TD1 (Hybrid~ma).*~ The human myelomonocytic cell line, KMT-2, established from CD34-positive cord blood cells% was used as a control.
Poly(A)+ RNA was isolated from PA-6 stimulated with LPS/TPA and used to construct a cDNA expression library in the CDM8 vector according to the method of Aruffo and Seed.27 About 4 kg of poly(A)+RNA yielded 1.11 X lo6 CTLL (T cDNA library screening. Isolation and analysis of RNA. RNA was isolated from whole cells by the LiCVurea method." Poly(A)+RNA was isolated using oligo(dT)-cellulose, electrophoresed and transferred to nitrocellulose membranes.
Sequencingofgenomic DNA. Genomic DNA was obtained from adult murine liver and propagated by polymerase chain reaction (PCR) for sequencing into pTM1000, by dideoxy chain termination using a kit supplied by Amersham. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
B (antisense); tail portion of exon 8, and 5'-TCACAG?TCTGTGT-CAGCCAC-3'. The probe for specific clone no. 2 was also synthesized. The sequences of primers were (1) head of exon X described later, 5'-GAGCTGGAACCTTGATGGCTG-3' and (2) tail portion of exon X, 5'-CTGGACAGTATAGAAATAAAG-3'.
As the PCR control, a murine p-actin oligonucleotide was also synthesized. The sequences were 5'-TCGTGCGTGACATCAAA-GAG3', and 5'-TGGACAGTGAGGCCAGGATG-3'. These primers were synthesized with a PCR-Mate DNA synthesizer (Model 391; Applied Biosystems Inc, Foster City, CA). The isolated poly(A)+ RNA was reverse transcribed in a total volume of 20 pL in buffer containing 50 mmol/L Tris-HC1 pH 8.3, 75 mmol/L KCI, 3 mmol/L MgCI,, 10 mmol/L dithiothreitol, a 10 mmol/L dNTP mixture, 100 pmol random hexamer oligonucleotides (Takara Shuzo, Kyoto, Japan), and 200 U of Moloney murine leukemia virus reverse transcriptase (BRL, Gaithersburg, MD). dsDNA was then synthesized from the ssDNA with 1 U of Thermus aquaticus (Taq) polymerase (Takara Shuzo), and two pairs of oligonucleotides (murine CD34 and murine p-actin), by 25 to 30 PCR cycles on a Perkin-Elmer Cetus PCR lo00 Thermocycler (Norwalk, CT). Each cycle included denaturation at 94°C for 1 minute, reannealing of the primer, and fragmentation at 55°C for 2 minutes, and polymerization at 72°C for 2 minutes.
A portion of each sample was separated by 5% polyacrylamide gel electrophoresis (PAGE), then transferred to a Hybond-N membrane (Amersham). Samples immobilized on the membrane were hybridized to a 32P-labeled probe of CD34 cDNA or murine p-actin cDNA (440 bp), which were amplified by PCR method according to the murine CD34 or murine p-actin cDNA sequence. The filter was washed twice in 2X SSC containing 0.2% SDS at 55°C for 30 minutes, then autoradiographed for 12 hours using an intensifying screen. The intensity of the bands in each lane was quantitatively determined by an AMBIS imaging system (AMBIS System Inc, San Diego, CA).
Southem blot analysis of PCR amplified murine CD34 DNA.
RESULTS
Initially, we screened cell lines expressing CD34 mRNA with a human CD34 probe. As shown in Fig 1, in addition to IL34ependent mouse myeloid cell lines such as IC-2 and DA-1, IL-la-stimulated PA-6 (mouse stromal cell line) showed significant cross hybridization. These data were (Fig 4) was inserted at the site of 964. Because there was the stop codon at 976, the intracellular portion of no. 2 was shorter than that of no. 6-2-2. Thus, no. 2 has a longer cDNA than no. 6-2-2, but the ORF is shorter than no. 6-2-2 by an inframe stop codon.
confirmed by Northern blot analysis using a murine cDNA probe that is described later (Fig 1) .
The murine CD34 cDNA homologous to human CD34 was then isolated from a cDNA library of LPS/TPAstimulated PA-6. From approximately 8 x 104 colonies, 9 were cloned, which ranged in size from 1.4 to 2. For is organized into eight exons distributed over 22 kb." According to the nomenclature of Brown et al no. 2 and no. 6-2-2 were identical in the corresponding coding regions between exons 1 and 7. The difference was in the cytoplasmic portion of CD34.
The nucleotide and amino acid sequences of both CD34 clones are shown in Fig 3. In clone no. 2, 156 new bp were inserted at nucleotide 964. Because there is a stop codon (TGA) at 976, the intracellular portion of no. 2 was shortened to 48 nucleotides or 16 amino acids, and it contained only two serine residues. In contrast, no. 6-2-2 had 10 serine residues. To clarify whether this difference was caused by alternative splicing, we investigated the genomic sequence of the intracellular portion (between 964 and 1,119 bp) that corresponds to the area between exons 7 and 8. We prepared genomic DNA from murine liver by PCR and sequenced it by the dideoxy chain termination. Figure 4 shows the genomic sequence consisting of 706 nucleotides which intervened between exon 7 and exon 8. The former 551 nucleotides were an intron and the latter 156 nucleotides were an exon that coded for clone no. 2. We designated this as exon X, which was continuous with the head of exon 8. The first two nucleotides at the 5' end of the intron were GT. The terminus of the intron and exon X ended with (pyrimidine),AG. These are the consensus sequence of the 5' and 3' splice junction. Thus, it is concluded that the two clones were caused by alternative splicing. Figure 5 shows the scheme of this alternative splicing. The longer cDNA clone (no. 2) contains an insert of 156 bp after exon 7. The exon X results in a shorter Actin Murine leukemic cell line (Ml) expressed a large amount of CD34 mRNA. When M1 cells were induced to differentiate into macrophages or granulocytes by IL-6, LIF, or G-CSF, expression of CD34 mRNA was suppressed (Fig 7) .
The expression of the CD34 gene was also examined in a variety of murine tissues. CD34 was abundantly expressed in the brain and testis, moderately in the thymus, spleen, and bone marrow, but not in adult liver (Fig 8A) . However, day 12 to 14 fetal liver cells expressed significant levels of CD34 (Fig 8B) . Probing Northern blots of murine tissue mRNAs showed that the murine homologue of the CD34 Fetal Liver cells For gene was expressed as a 2.5-to 2.7-kb mRNA, identical in mobility to the human mRNA.
To clarify the alternative splicing of CD34 gene in each murine cell line and tissue, we tested the expression of the two clones using RT-PCR (Fig 9) . Because the oligonucleotide of the tail of exon 7 was used as sense and that of the [the size of exon SI), and no. 6-2-2 as a band of 186 bp as shown in Fig 5. In Fig 9 , two bands were detected at almost equal levels in spleen, thymus, bone marrow, and testis, as well as unstimulated, stimulated PA-6 and DA-1. However, only in brain RNA, was the ratio (342bp:156bp) 2.6:1, suggesting that the expression of no. 2 was dominant compared with that of no. 6-2-2.
To confirm this alternative splicing, we performed the Northern blots using a exon X as the probe. As shown in Fig
10, significant expression of exon X or a novel clone no. 2 was detected in each organ.
DISCUSSION
To characterize the function of CD34 antigen experimentally, we isolated two types of CD34 mRNA from a cDNA library from a murine stromal cell line PA-6 stimulated with LPS/TPA. CD34 antigen was expressed in PA-6, which can support the growth of hematopoietic stem cells such as CFU-S, in addition to hematopoietic progenitors, thus providing a rationale for the tentative role of CD34 as an adhesion molecule. In our study, PA-6 did not express CD34 mRNA constitutively, but it was induced to express CD34 by IL-la, LPS/TPA, or cell contact. The other stromal cell, ST-2, which can support lymphopoiesis but not CFU-S, did not express CD34 mRNA even in the stimu-+28S mCD34 IL34ependent mouse myeloid cell lines such as DA-1 and IC-2 showed high expression of CD34 mRNA. CD34 mRNA was expressed in mouse myeloid leukemia cell line (Ml), and it was downregulated by the induction of their differentiation to macrophages with IL-6, LIF, or G-CSF. CD34 mRNA was highly expressed in testis and brain, when compared with hematopoietic cells such as spleen, thymus, and bone marrow cells. Active hematopoietic organs, fetal liver cells expressed CD34 mRNA, whereas adult liver cells did not. Although c-kit mRNA was expressed during 12 to 20 days of gestation (data not shown), CD34 mRNA was expressed only on days 12 to 14. It has been previously reported that embryonic fibroblast lines express CD34 mRNA.13 Thus, it is speculated that the CD34 antigen is involved in the early stage of embryogenesis as well as that of hematopoiesis.
We show here the alternative splicing results in two types of CD34 mRNA. The nucleotide sequences at each exonintron junction are remarkably conserved in virtually all nuclear mRNA genes of almost all species that have been studied. The first two nucleotides at the 5' end of the intron in RNA are virtually always GU and the 3' terminus of the intron invariably ends with AG.29 The CD34 intron shows the consensus sequence described above.
The murine CD34 cDNA (no. 6-2-2) described above is highly homologous with the human CD34 cDNA sequence (D. Simmons and B. Seed). The homology was higher at the 3' end of the gene than at the 5' region. However, in the cytoplasmic domain, no. 2 of the murine CD34 lacked the homology with the human CD34 which was cloned by Simmons and Seed. Recently, a novel human CD34 cDNA, which was homologous to no. 2 of the murine CD34, has been cloned (Y, Nakamura and H. Nakauchi, personal communication, 1991) . The predicted amino acid sequence of murine CD34 is highly homologous with human CD34 at 93% (68 of 73) at the level of amino acid. Fackler et a130 found that CD34 is a phosphoprotein and that activation of protein kinase C (PKC) enhanced CD34 phosphorylation. Only serine phosphorylation was detected. The predicted internal portion of the protein appears to contain basic amino acid residues adjacent to serine residues that represent at least two potential target sites for PKC phosphorylation. Thus, potential target sites for PKC are the two serines at 306 and 364 of human amino acid CD34. This region is highly conserved in murine CD34. Fackler et aPO speculated that the serine from the latter of the two PKC sites may also serve as the distal phosphoserine in a consensus motif potentially recognized by glycogen synthase kinase-3 (Fa) (Ser[XI4Ser [P] ). Because the serine at 364 was missing in no. 2, it may cause a change in signal transduction.
The relative intensities of the quantitative RT-PCR bands obtained from different tissues were variable. Especially in the brain, no. 2 was expressed more than no. 6-2-2. Densitometry of the RT-PCR data indicated a ratio (clone no. 2: clone no. 6-2-2) approximately 2.6:l in the brain. In contrast, spleen, thymus, bone marrow, and testis RNA gave two bands of almost equal intensity, with a molar ratio ranging between 0.83 and 1.10. It is suggested that the ratio of the corresponding mRNAs varies in a tissue specific manner.
Recently, tissue-specific alternative splicing has revealed two types of c-kit ligand growth factor (KL) mRNA.31 One produced the soluble form of KL at relatively high levels, whereas the other preferentially gave the cell surface form. Thus, it is interesting to clarify the two clones of mCD34 at the cellular level, especially in the brain, by in situ hybridization.
In our two CD34 clones, it may be involved in transduction of signal(s) that ultimately lead to cellular activation events including proliferation, differentiation, and/or cellular adhesion. The isolation of the two types of murine cDNA will extend the variety of approaches to identify the range of CD34 functions, not only in the hematopoiesis and but also in other systems.
